CP-547,632
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CP-547,632, covering 2013-12-19 to 2013-12-19. Get the full timeline:
Most recent: Clinical Trial Update: CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]